Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases
Micheal O. Avoseh, Hua Jin, Oscar Moreno, Andrea T. Obi, Peter K. Henke, Souvik Sen, Michael A. Matthay, You-Yang Zhao, Colin E. Evans · 2026
Read Endothelium-targeted and untargeted nanoparticle therapies in thromboinflammatory vascular diseases by Micheal O. Avoseh, Hua Jin, Oscar Moreno, Andrea T. Obi, Peter K. Henke, Souvik Sen, Michael A. Matthay, You-Yang Zhao, Colin E. Evans (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13676217.txt.
Description
Micheal Avoseh and co-authors review, in 2026, tiny drug carriers aimed at the lining of blood vessels. That lining helps control blood flow, swelling, and clotting. When it fails, it drives diseases such as hardened arteries, stroke, and severe infection.
Drugs given to the whole body often miss the diseased lining and cause side effects elsewhere. Carriers built to home in on lining cells can pile the drug where it is needed. The review walks through studies of both aimed and unaimed carriers in these vessel diseases. It also weighs the hurdles that still block routine use. Readers get a clear view of a delivery idea that could sharpen many vessel treatments at once.
Catalog record
| CREATOR | Micheal O. Avoseh, Hua Jin, Oscar Moreno, Andrea T. Obi, Peter K. Henke, Souvik Sen, Michael A. Matthay, You-Yang Zhao, Colin E. Evans |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |